Interrupted serial sections of the foot region from 14 human fetuses, crown-rump (CR) lengths between 32 and 240 mm, were studied, using HE, PAS, Alcian blue, Gomori’s trichrome and von Kossa stains. Cartilage canals carrying vascular connective tissue from the perichondrium entered the talus by 68-mm. The centre of ossification developed in the neck region of the talus cartilage by 240 mm CR length, but early stages of chondrocyte proliferation and hypertrophy were noted by 108-mm CR length. The latter is marked by 170 mm CR length. A number of cartilage canals were observed around the developing centre. Branches from these cartilage canals appeared to supply vascular osteogenic tissue to its marrow spaces.

This study was undertaken to isolate a flavonol, kaempferol, from the fruits of Lagenaria siceraria (bottle gourd) as a sole compound and to explore the fibrinolytic potential of the methanolic extract of the fruits of L. siceraria and the isolated compound using their in vitro activity. The fibrinolytic activity in terms of percentage of plasma clot liquefaction was determined by plasma clot lysis at 37°C in 24 h. The fibrinolytic activity of both substances was compared to the well-known thrombolytic agent streptokinase (30,000 IU). The percentage of fibrinolytic activity of the extract and isolated compound were found to be 54.72 ± 0.7210 and 77.37 ± 1.3010, respectively. Streptokinase was considered as the standard fibrinolytic enzyme for comparative purposes and had 91.46 ± 0.7625% fibrinolytic activity. The conclusion drawn in our study after testing the hypothesis by experimental procedures is that in vitro fibrinolytic activity on plasma clots is an inherent property of kaempferol isolated from the fruits of L. siceraria, and its comparison with streptokinase is a new aspect for further study.